Citations

Showing 10 of 108119 citations.

Considerations With Regard to the Relationship Between Anticoagulant Intake and Glaucoma Prognosis in Eyes With Optic Disc Hemorrhages
Rocha, Janaina A.G. , Carvalho, Carolina Rodrigues de, Scoralick, Ana Luiza Bassoli , Dias, Diego Torres , Prata, Tiago S.

Mayo Clinic

Journal of Glaucoma | April 27, 2019 | Volume: 28 | Issue: 7 | Pages: e133-e133

10.1097/ijg.0000000000001265 | PMID 30994487 Get It

Recommendations for Tissue Microarray Construction and Quality Assurance
Glinsmann‐Gibson, Betty, Wisner, Lee, Stanton, Melissa, Larsen, Brandon T. , Maguire, Alanna , Maguire, Alanna , Larsen, Brandon, Rimsza, Lisa, Rimsza, Lisa M. , Maguire, Alanna

Mayo Clinic

Applied Immunohistochemistry & Molecular Morphology | April 27, 2019 | Volume: 28 | Issue: 4 | Pages: 325-330

10.1097/pai.0000000000000739 | PMID 31033496 Get It

Tissue microarrays (TMAs) are important tools to conserve precious tissue resources from increasingly smaller biopsies and to control experimental costs and variation across sample sets. The quality assurance assessment of TMA materials created at centralized biobanks has not been standardized. Herein, we outline 2 processes for the construction of TMAs (“recipient block” and “tape” methods) and the associated preconstruction quality control measures (pathology review, protein and RNA assessment, map creation, and storage conditions) developed by the AIDS Cancer Specimen Resource (ACSR) Network’s Science and Technology Core. These steps provide a suggested framework for quality assessment that allows end-users, receiving materials from tissue banks, confidence in their experimental results.
Family Medicine Patients Have Shorter Length of Stay When Cared for on a Family Medicine Inpatient Service
Garrison, Gregory M. , Keuseman, Rachel , Boswell, Christopher L. , Horn, Jennifer L. , Nielsen, Nathaniel T., Nielsen, Megan , Keuseman, Rachel L, Nielsen, Megan L, Nielsen, Megan L.

Mayo Clinic

Journal of Primary Care & Community Health | April 27, 2019 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2150132719840517 | PMID 31027438 Get It

Introduction: Hospitalists have been shown to have shorter lengths of stays than physicians with concurrent outpatient practices. However, hospitalists at academic medical centers may be less aware of local resources that can support the hospital to home transition for local primary care patients. We hypothesized that local family medicine patients admitted to a family medicine inpatient service have shorter length of stay than those admitted to general hospitalist services which also care for tertiary patients at an academic medical center. Methods: A retrospective cohort study was conducted at an academic medical center with a department of family medicine providing primary care to over 80 000 local patients. A total of 3100 consecutive family medicine patients admitted to either the family medicine inpatient service or a general medicine inpatient service over 3 years were studied. The primary outcome was length of stay, which was adjusted using multivariate linear regression for demographics, prior utilization, diagnosis, and disease severity. Results: Adjusted length of stay was 33% longer (95% CI 24%-44%) for local family medicine patients admitted to general medicine inpatient services as compared with the family medicine inpatient service. Readmission rates within 30 days were not different (19% vs 16%, P = .14). Conclusions: Local primary care patients were safely discharged from the hospital sooner on the family medicine inpatient service than on general medicine inpatient services. This is likely because the family physicians staffing their inpatient service are more familiar with outpatient resources that can be effectively marshaled to help local patients with the transition from hospital to home.
A brief history of “Alzheimer disease”
Petersen, Ronald C. , Jack, Clifford R. , Jack, Clifford R , Knopman, David S.

Mayo Clinic

Neurology | April 27, 2019 | Volume: 92 | Issue: 22 | Pages: 1053-1059

10.1212/wnl.0000000000007583 | PMID 31028129 Get It

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest
Werf, Christian van der , Lieve, Krystien V.V. , Bos, J. Martijn , Lane, Conor M. , Rosés‐Noguer, Ferran , Aiba, Takeshi , Wada, Yuko , Ingles, Jodie , Leren, Ida S. , Rudic, Boris , Maltret, Alice , Sacher, Frédéric , Skinner, Jonathan R. , Roston, Thomas M. , Tfelt‐Hansen, Jacob , Swan, Heikki, Robyns, Tomas , Ohno, Seiko , Roberts, Jason D. , Berg, Maarten P. van den , Kammeraad, Janneke A.E. , Blom, Nico A, Behr, Elijah R. , Borggrefe, Martin , Haugaa, Kristina H. , Semsarian, Christopher , Horie, Minoru , Till, Janice, Ackerman, Michael J. , Wilde, Arthur A.M. , Horie, Minoru , Behr, Elijah Raphael , Bos, Johan M , Tfelt-Hansen, Jacob , Skinner, Jonathan R , van den Berg, Maarten P , Robyns, Tomas , Haugaa, Kristina , Wada, Yuko , van der Werf, Christian , Rosés-Noguer, Ferran , Denjoy, Isabelle , Aiba, Takeshi , Schwartz, Peter J. , Krahn, Andrew D. , Ohno, Seiko , Probst, Vincent , Kannankeril, Prince J. , Blom, Nico A. , Shimizu, Wataru , Leenhardt, Antoine , Ingles, Jodie , Lieve, Krystien V

Mayo Clinic

European Heart Journal | April 26, 2019 | Volume: 40 | Issue: 35 | Pages: 2953-2961

10.1093/eurheartj/ehz309 | PMID 31145795 Get It

Abstract Aims In patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), implantable cardioverter-defibrillator (ICD) shocks are sometimes ineffective and may even trigger fatal electrical storms. We assessed the efficacy and complications of ICDs placed in patients with CPVT who presented with a sentinel event of sudden cardiac arrest (SCA) while undiagnosed and therefore untreated. Methods and results We analysed 136 patients who presented with SCA and in whom CPVT was diagnosed subsequently, leading to the initiation of guideline-directed therapy, including β-blockers, flecainide, and/or left cardiac sympathetic denervation. An ICD was implanted in 79 patients (58.1%). The primary outcome of the study was sudden cardiac death (SCD). The secondary outcomes were composite outcomes of SCD, SCA, appropriate ICD shocks, and syncope. After a median follow-up of 4.8 years, SCD had occurred in three patients (3.8%) with an ICD and none of the patients without an ICD (P = 0.1). SCD, SCA, or appropriate ICD shocks occurred in 37 patients (46.8%) with an ICD and 9 patients (15.8%) without an ICD (P < 0.0001). Inappropriate ICD shocks occurred in 19 patients (24.7%) and other device-related complications in 22 patients (28.9%). Conclusion In previously undiagnosed patients with CPVT who presented with SCA, an ICD was not associated with improved survival. Instead, the ICD was associated with both a high rate of appropriate ICD shocks and inappropriate ICD shocks along with other device-related complications. Strict adherence to guideline-directed therapy without an ICD may provide adequate protection in these patients without all the potential disadvantages of an ICD.
Endocannabinoids and Stroke Prevention: Review of Clinical Studies
Ebbert, Jon O. , Scharf, Eugene

Mayo Clinic

Cannabis & Cannabinoid Research | April 26, 2019 | Volume: 5 | Issue: 1 | Pages: 6-11

10.1089/can.2018.0066 | PMID 32322672 Get It

The societal burden of ischemic stroke suggests a need for additional therapeutic categories in stroke prevention. Modulation of the endocannabinoid system (ECS) is a rational target for stroke prevention because of its effects on inflammation, vascular tone, and metabolic balance, all well-described stroke risk factors. In this article, we summarize the existing ECS clinical studies in human subjects' research as they relate to conventional vascular risk factors associated with ischemic stroke. To date, 2-arachidonoylglycerol (2-AG) derivative endocannabinoids are consistently reported to be elevated in insulin resistance, whereas the N-arachidonoylethanolamine (AEA) endocannabinoid derivatives are elevated in obesity. The ECS role in metabolic health should examine the effects of 2-AG reduction and AEA augmentation as a means of stroke risk reduction. Cannabinoid receptors are reported on macrophages within atherosclerotic plaques and suggest a role for immunomodulation as a therapeutic for atherosclerosis through both peripheral immune cell CB1 antagonism and/or CB2 agonist. The effects of ECS on hypertension, smoking, physical activity, obstructive sleep apnea, heart failure, and atrial fibrillation are incompletely described and deserve further study. A limitation to ECS research is significant overlap with noncannabinoid molecular targets. Further exploration of the ECS needs to include the larger metabolomics context for a greater understanding of its therapeutic potential. Clinical translational studies in stroke prevention should be directed at ECS in metabolic balance and atherosclerosis.
Sex Disparities in First Medical Contact of Patients with Suspected Acute Coronary Syndrome Using Telemedicine Technology
Maor, Elad , Abend, Yitzhak, Ganem, Diab, Kusniec, Fabio, Grosman‐Rimon, Liza , Carasso, Shemy , Amir, Offer, Maor, Elad , Elbaz‐Greener, Gabby , Lerman, Amir

Mayo Clinic

Telemedicine and e-Health | April 26, 2019 | Volume: 26 | Issue: 4 | Pages: 411-418

10.1089/tmj.2019.0036 | PMID 31025897 Get It

Background: Reducing door-to-balloon time may not reduce mortality, but reducing the time from symptom onset to first medical contact (FMC) may alone improve patient outcomes. The purpose of this study was to focus on analyzing sex differences in FMC call delay and its trend over the decades in patients with suspected acute coronary syndrome (ACS). Methods: Large private telemedicine data in patients with suspected ACS were used to investigate time delay in contacting a telemedicine call center. We identified 24,592 calls to a primary call center of patients with anginal symptoms and first electrocardiogram (ECG), using mobile 12-lead ECG devices. For the purpose of the current analysis, we included the first call of 14,420 patients for whom demographic, clinical ECG data were available. Results: First mobile ECG changes included suspected S-T Segment (ST) elevation in 2,220 (16%) cases, ST depression in 3,143 (22%) cases, or both in 685 (5%) patients. There were 6,721 (47%) calls to the center within less than 1 h of symptom onset. Chest pain, dyspnea, heart rate, male sex, absence of diabetes mellitus, early time period of the study, and ischemic ST segment changes on the first ECG were all independently associated with the increased likelihood of contacting the center within less than 1 h of symptom onset to FMC ( p < 0.01 for all). Conclusions: Both chest pain and ischemic ECG changes were sex dependent for early medical contact, as such factors were significant among men ( p = 0.001 and p = 0.024, respectively), but not among women ( p = 0.024). The later time period of the study was associated with a shorter time delay among women more than that of men ( p = 0.014). Women with prehospital chest pain or ischemic ST segment changes tend to seek medical help later than men. Temporal trends show attenuation of this sex disparity, with more women presenting earlier in the last decade.
Comparison of Patient‐Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT‐AF Registry
Perino, Alexander C., Shrader, Peter, Turakhia, Mintu P., Ansell, Jack E., Gersh, Bernard J., Fonarow, Gregg C., Go, Alan S., Kaiser, Daniel W., Hylek, Elaine M., Kowey, Peter R., Singer, Daniel E., Thomas, Laine, Steinberg, Benjamin A., Peterson, Eric D., Piccini, Jonathan P., Mahaffey, Kenneth W., Mahaffey, Kenneth W. , Turakhia, Mintu P. , Turakhia, Mintu P , Perino, Alexander C., Shrader, Peter, Ansell, Jack E., Gersh, Bernard J., Fonarow, Gregg C., Go, Alan S., Kaiser, Daniel W., Hylek, Elaine M., Kowey, Peter R., Singer, Daniel E., Thomas, Laine, Steinberg, Benjamin A., Peterson, Eric D., Piccini, Jonathan P.

Mayo Clinic

Journal of the American Heart Association | April 26, 2019 | Volume: 8 | Issue: 9 | Pages: No page available

10.1161/jaha.118.011205 | PMID 31023126 Get It

Background Patient satisfaction with therapy is an important metric of care quality and has been associated with greater medication persistence. We evaluated the association of patient satisfaction with warfarin therapy to other metrics of anticoagulation care quality and clinical outcomes among patients with atrial fibrillation ( AF ). Methods and Results Using data from the ORBIT ‐ AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry, patients were identified with AF who were taking warfarin and had completed an Anti‐Clot Treatment Scale ( ACTS ) questionnaire, a validated metric of patient‐reported burden and benefit of oral anticoagulation. Multivariate regressions were used to determine association of ACTS burden and benefit scores with time in therapeutic international normalized ratio range ( TTR ; both ≥75% and ≥60%), warfarin discontinuation, and clinical outcomes (death, stroke, major bleed, and all‐cause hospitalization). Among 1514 patients with AF on warfarin therapy (75±10 years; 42% women; CHA 2 DS 2 ‐ VAS c 3.9±1.7), those most burdened with warfarin therapy were younger and more likely to be women, have paroxysmal AF , and to be treated with antiarrhythmic drugs. After adjustment for covariates, ACTS burden scores were independent of TTR ( TTR ≥75%: odds ratio, 1.01 [95% CI , 0.99–1.03]; TTR ≥60%: odds ratio, 1.01 [95% CI , 0.98–1.05]), warfarin discontinuation (odds ratio, 0.99; 95% CI , 0.97–1.01), or clinical outcomes. ACTS benefit scores were also not associated with TTR , warfarin discontinuation, or clinical outcomes. Conclusions In a large registry of patients with AF taking warfarin, ACTS scores provided independent information beyond other traditional metrics of oral anticoagulation care quality and identified patient groups at high risk for dissatisfaction with warfarin therapy.
Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study
Andersson, Johanna , Khan, Zaraq , Weaver, Amy L. , Vaughan, Lisa E. , Gemzell‐Danielsson, Kristina , Andersson, Johanna K , Stewart, Elizabeth A.

Mayo Clinic

Acta Obstetricia et Gynecologica Scandinavica | April 26, 2019 | Volume: 98 | Issue: 10 | Pages: 1341-1350

10.1111/aogs.13632 | PMID 31025313 Get It

AbstractIntroductionAdenomyosis is a benign uterine disease where endometrial glands and stroma are found within the myometrium surrounded by an area of hypertrophic myometrium. Symptomatology includes heavy menstrual bleeding and pelvic pain. The pathogenesis of adenomyosis is not known; however, animal models have shown increased uterine concentration of prolactin as a risk factor. Prolactin acts as a smooth muscle cell mitogen. If prolactin is central to adenomyosis pathogenesis, reducing uterine prolactin could be a possible medical treatment option. In this pilot study, we aim to evaluate the effect of bromocriptine, a prolactin inhibitor, on menstrual bleeding and pain in women with adenomyosis.Material and methods23 women with diffuse adenomyosis were enrolled from a university hospital in Sweden and a tertiary care center in the USA. Nineteen patients completed 6 months of treatment with vaginal bromocriptine at a dose of 5 mg daily. Participants completed validated measures at baseline, 3 and 6 months of treatment, and at 9 months (3 months after cessation of bromocriptine). Validated measures utilized included Pictorial Blood Loss Assessment Chart (PBLAC), Aberdeen Menorrhagia Clinical Outcomes Questionnaire (AMCOQ), Visual Analog Scale for pain (VAS), McGill Pain Questionnaire (MPQ), Endometriosis Health Profile (EHP‐30), Female Sexual Function Index (FSFI) and the Fibroid Symptom Quality of Life (UFS‐QOL) symptom severity and health‐related quality of life (HRQL) subscores. Scores were compared between baseline and 9 months using the Wilcoxon signed rank test.ResultsMean age of participants was 44.8 years. About 77.8% reported PBLAC scores >250 and 68.4% reported moderate to severe pain at baseline. Compared with baseline, women had lower 9‐month scores (median [interquartile range] for all) on PBLAC (baseline 349 [292‐645] vs 9‐month 233 [149‐515], P = 0.003), VAS (5.0 [4‐8.3] vs 2.5 [0‐4.5], P < 0.001), EHP Core Pain (15.9 [9.1‐50.0] vs 3.4 [2.3‐34.1], P = 0.029), EHP Core Self‐image (41.7 [16.7‐58.3] vs 25 [0‐5], P = 0.048) and Symptom Severity Score (60 [44‐72] vs 44 [25‐56], P < 0.001) and higher HRQL scores (57 [37‐63] vs 72 [51‐85], P < 0.001) following bromocriptine treatment. Other EHP core parameters and FSFI were not significantly different.ConclusionsSignificant improvement in menstrual bleeding, pain and quality of life after vaginal bromocriptine treatment suggests a novel therapeutic agent for adenomyosis.
Comparison of changes in rectal area and volume during MR evacuation proctography in healthy and constipated adults
Narayanan, Susrutha Puthanmadhom, Sharma, Mayank , Karwoski, Ronald A., Holmes, David R. , Bharucha, Adil E. , Puthanmadhom Narayanan, Susrutha, Bharucha, A E , Fletcher, Joel G.

Mayo Clinic

Neurogastroenterology & Motility | April 26, 2019 | Volume: 31 | Issue: 7 | Pages: No page available

10.1111/nmo.13608 | PMID 31025437 Get It

AbstractBackgroundDuring proctography, rectal emptying is visually estimated by the reduction in rectal area. The correlation between changes in rectal area, which is a surrogate measure of volume, is unclear. Our aims were to compare the change in rectal area and volume during magnetic resonance (MR) proctography and to compare these parameters with rectal balloon expulsion time (BET).MethodsIn 49 healthy and 46 constipated participants, we measured BET and rectal area and volume with a software program before and after participants expelled rectal gel during proctography.Key ResultsAll participants completed both tests; six healthy and 17 constipated patients had a prolonged (>60 seconds) BET. During evacuation, the reduction in rectal area and volume was lower in participants with an abnormal than a normal BET (P < 0.01). The reduction in rectal area and volume were strongly correlated (r = 0.93, P < 0.001) and equivalent for identifying participants with abnormal BET. Among participants with less evacuation, the reduction in rectal area underestimated the reduction in rectal volume. A rectocele larger than 2 cm was observed in eight of 18 (44%) participants in whom the difference between change in volume and area was ˃10% but only 14 of 77 (18%) participants in whom the difference was ≤10% (P = 0.03).ConclusionsMeasured with MR proctography, the rectal area is reasonably accurate for quantifying rectal emptying and equivalent to rectal volume for distinguishing between normal and abnormal BET. When evacuation is reduced, the change in rectal area may underestimate the change in rectal volume.